How the insula region shapes alcohol's unpleasant effects
Role of insula circuitry in the regulation of the aversive properties of ethanol
Researchers are looking at how a brain area called the insula changes how unpleasant alcohol feels, which may help explain why some people end up drinking too much.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project ID | NIH-11238100 on NIH RePORTER |
What this research studies
From a patient's point of view, scientists will use animal models to see how connections in the insula part of the brain control alcohol's aversive or unpleasant effects. They will use conditioned taste aversion, a lab test where a taste is paired with an unpleasant feeling, to measure sensitivity to alcohol. The team will compare animals with dependence-like drinking to controls to see if sensitivity to those unpleasant effects drops as dependence emerges. Findings will map the specific brain circuits involved and could point to targets for future human treatments.
Who could benefit from this research
Good fit: This work is most relevant to people who struggle with heavy alcohol use or alcohol dependence and are interested in new treatment approaches.
Not a fit: People who drink only socially, who have no history of problem drinking, or whose issues are unrelated to changes in alcohol aversion are unlikely to benefit directly from this research.
Why it matters
Potential benefit: If successful, this work could point to new ways to restore sensitivity to alcohol's unpleasant effects and help reduce heavy drinking and relapse risk.
How similar studies have performed: Past animal studies link reduced sensitivity to alcohol's unpleasant effects with heavier drinking and use conditioned taste aversion as a validated model, but focusing on insula circuitry as a target is a relatively new direction.
Where this research is happening
Chapel Hill, United States
- Univ of North Carolina Chapel Hill — Chapel Hill, United States (Active)
Researchers
- Principal investigator: Kash, Thomas L. — Univ of North Carolina Chapel Hill
- Study coordinator: Kash, Thomas L.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.